- Home
- ONC vs GEHC Comparison
ONC vs GEHC Comparison
Compare ONC & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONC
- GEHC
- Stock Information
- Founded
- ONC 2010
- GEHC 1892
- Country
- ONC Switzerland
- GEHC United States
- Employees
- ONC N/A
- GEHC N/A
- Industry
- ONC Biotechnology: Pharmaceutical Preparations
- GEHC Computer Software: Prepackaged Software
- Sector
- ONC Health Care
- GEHC Technology
- Exchange
- ONC Nasdaq
- GEHC Nasdaq
- Market Cap
- ONC 37.2B
- GEHC 32.9B
- IPO Year
- ONC N/A
- GEHC N/A
- Fundamental
- Price
- ONC $313.67
- GEHC $75.22
- Analyst Decision
- ONC Strong Buy
- GEHC Strong Buy
- Analyst Count
- ONC 9
- GEHC 10
- Target Price
- ONC $335.78
- GEHC $89.10
- AVG Volume (30 Days)
- ONC 410.3K
- GEHC 4.1M
- Earning Date
- ONC 08-06-2025
- GEHC 07-30-2025
- Dividend Yield
- ONC N/A
- GEHC 0.18%
- EPS Growth
- ONC N/A
- GEHC 41.40
- EPS
- ONC N/A
- GEHC 4.88
- Revenue
- ONC $4,562,002,000.00
- GEHC $19,967,000,000.00
- Revenue This Year
- ONC $865.19
- GEHC $6.09
- Revenue Next Year
- ONC $21.12
- GEHC $4.65
- P/E Ratio
- ONC N/A
- GEHC $15.41
- Revenue Growth
- ONC 47.33
- GEHC 2.31
- 52 Week Low
- ONC $170.99
- GEHC $57.65
- 52 Week High
- ONC $330.63
- GEHC $94.80
- Technical
- Relative Strength Index (RSI)
- ONC 61.68
- GEHC 56.21
- Support Level
- ONC $301.33
- GEHC $72.97
- Resistance Level
- ONC $330.63
- GEHC $74.39
- Average True Range (ATR)
- ONC 9.12
- GEHC 1.33
- MACD
- ONC -0.19
- GEHC 0.22
- Stochastic Oscillator
- ONC 66.43
- GEHC 94.39
About ONC BeiGene Ltd. American Depositary Shares
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne's revenue.
About GEHC GE HealthCare Technologies Inc.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).